**Neuralink获FDA批准进行第二位脑机接口受试者手术，计划六月执行**
据《华尔街日报》报道，美国食品药品监督管理局（FDA）已批准神经科技公司Neuralink为第二名患者植入脑芯片。这一消息标志着这家由埃隆·马斯克支持的公司在脑机接口领域的又一重要进展。
据悉，Neuralink的此次手术计划紧随首位受试者手术之后，旨在进一步完善并推广其脑机接口技术。在针对首位受试者过程中出现的问题，Neuralink提出了详尽的修复方案并获得FDA批准。知情人士透露，在获得相关监管机构的批准后，Neuralink正计划于六月份为第二名受试者进行芯片植入手术。
这一技术的发展代表着人类与电子设备交互方式的一大飞跃。分析师认为，Neuralink的突破不仅能够助力神经科学研究，还可能在改善残障人士的康复能力、增强认知能力等方面发挥巨大潜力。目前，业界对于Neuralink的技术进展充满期待，并密切关注其后续进展与潜在风险。
英语如下：
News Title: “Neuralink’s Breakthrough in Brain-Computer Interface with FDA Update: Two Cases of Implantation Initiated”
Keywords: Neuralink, Brain-Computer Interface, Subject
News Content: **Neuralink Gets FDA Approval for Second Brain-Computer Interface Subject Surgery, Scheduled for June**
According to the Wall Street Journal, the US Food and Drug Administration (FDA) has approved Neuralink Technologies for implanting brain chips in the second patient. This news marks another significant breakthrough for the Elon Musk-backed company in the field of brain-computer interfaces.
It is understood that Neuralink’s surgical plan follows the first subject surgery, aiming to further refine and promote its brain-computer interface technology. Addressing the issues encountered during the first subject’s procedure, Neuralink has developed a detailed repair plan and received FDA approval. Sources familiar with the matter have revealed that after obtaining approval from relevant regulatory agencies, Neuralink is planning to implant the chip in the second subject in June.
The development of this technology represents a significant leap in the way humans interact with electronic devices. Analysts believe that Neuralink’s breakthrough not only aids in neuroscience research but also holds tremendous potential in improving rehabilitation abilities and cognitive enhancement for individuals with disabilities. Currently, the industry is full of expectations for Neuralink’s technological advancements and is closely monitoring its subsequent progress and potential risks.
【来源】https://www.ithome.com/0/769/383.htm
Views: 2